PATENT CLAIM ANALYSIS

Application Number: 15902690
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "023000"]

Abstract:
Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae virus infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula IV: The compounds, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola virus and Cueva virus infections.

Claim (Index 28):
The pharmaceutical composition of  claim 25  wherein R 7  is: wherein R f  is selected from the group of H, C 1 -C 8  alkyl, benzyl, C 3 -C 6  cycloalkyl, and \u2014CH 2 \u2014C 3 -C 6  cycloalkyl.

Metadata:
- Claim Count in Document: 58.0
- Percentile: 88.0
- Lexical Diversity: 1.55882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15246240', '14926062', '15267433', '12013640', '14830121']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7378437876562748
- 35 USC 102 Novelty (BERT): 0.5936709819246102
- Combined Prediction Score: 0.7234265070831083
- Mean Citation Score: 334.652744
- Max Citation Score: 450.78598
- Similarity Product: 326.9161982599878

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test